Carthera

📍 Lyon, France🗓 Founded 2010👥 33 employees💰 Last funded Sep 2022
Medical Equipment Manufacturing🌐 carthera.eu
Website LinkedIn
Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS). The products developed by Carthera® are in clinical or preclinical evaluation (not FDA or CE approved) and are not available for sale.
3
Total investors
0
Early stage
1
Mid stage
1
Late stage
2010
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
1
United States
1
Investor activity2015–2022 · investors recorded per year
201512020120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Carthera?
Carthera has 3 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Carthera last raise funding?
The most recent investment in Carthera recorded on gritt.io was in September 2022.
When was Carthera founded?
Carthera was founded in 2010.
What industry is Carthera in?
Carthera operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Carthera based?
Carthera is headquartered in Lyon, France.